semaj83/ctmatch_classification huggingface dataset:
Patient description: The patient is a 55-year-old man who was recently diagnosed with Parkinson's disease. He is complaining of slowness of movement and tremors. His disease is ranked as mild, Hoehn-Yahr Stage I. His past medical history is significant for hypertension and hypercholesterolemia. He lives with his wife. They have three children. He used to be active with gardening before his diagnosis. He complains of shaking and slow movement. He had difficulty entering through a door, as he was frozen and needed guidance to step in. His handwriting is getting smaller. He is offered Levodopa and Trihexyphenidyl. He is an alert and cooperative man who does not have any signs of dementia. He does not smoke or use any illicit drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Parkinson's Disease Diagnosis of Parkinson's Disease with a rating of 1.5-4 on the Modified Hoehn and Yahr Scale of Parkinson's Disease Progression Endorsement of FoF,44 able to stand and walk 10 meters with or without an assistive device >18 years old; able to speak English Score >4 out of 6 on the short Mini Mental Status Exam Able and willing to attend twice weekly sessions for 8 weeks  People with self-reported life expectancy <12 months Inability to attend sessions due to transportation issues Current involvement with other physical activity (including yoga), rehabilitation, or other intervention studies Inability or refusal to provide informed consent
Patient description: The patient is a 55-year-old man who was recently diagnosed with Parkinson's disease. He is complaining of slowness of movement and tremors. His disease is ranked as mild, Hoehn-Yahr Stage I. His past medical history is significant for hypertension and hypercholesterolemia. He lives with his wife. They have three children. He used to be active with gardening before his diagnosis. He complains of shaking and slow movement. He had difficulty entering through a door, as he was frozen and needed guidance to step in. His handwriting is getting smaller. He is offered Levodopa and Trihexyphenidyl. He is an alert and cooperative man who does not have any signs of dementia. He does not smoke or use any illicit drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Mental Health Crisis for being referred to the crisis centre's Information Class and thus, for participation in the study are presenting to the walk-in service with a mental health-related crisis (e.g., difficulty coping with acute stressors, suicidality) a willingness by the client to participate in class-based or group interventions the ability to attend and have transportation to services during daytime hours the client is not better served by another service for their presenting problem (e.g., Addictions Foundation of Manitoba when alcohol or substance is primary) the client is literate and will be able to understand and benefit from attending class-based or group psychotherapy interventions, and the client is not being admitted to the Crisis Stabilization Unit or hospital (i.e., is not at imminent risk of harming themselves or others)
Patient description: The patient is a 55-year-old man who was recently diagnosed with Parkinson's disease. He is complaining of slowness of movement and tremors. His disease is ranked as mild, Hoehn-Yahr Stage I. His past medical history is significant for hypertension and hypercholesterolemia. He lives with his wife. They have three children. He used to be active with gardening before his diagnosis. He complains of shaking and slow movement. He had difficulty entering through a door, as he was frozen and needed guidance to step in. His handwriting is getting smaller. He is offered Levodopa and Trihexyphenidyl. He is an alert and cooperative man who does not have any signs of dementia. He does not smoke or use any illicit drugs.

Clinical trial eligibility criteria: eligible ages (years): 65.0-80.0,  Parkinson Disease diagnosis of Parkinson's disease according to the United Kingdom Brain Bank criteria in stage 2-3 of the disease evolution according to the Hoehn and Yahr treated with levodopa or its synergists capable to walk independently indoors without aid referring 5 years of education or more  presence of other neurological (excluding PD), orthopedic or cardiopulmonary problems visual and auditory deficiency uncorrected dementia [assessed by Montreal Cognitive Assessment (MoCA), cut-off 26] depression [according to the Geriatric Depression Scale (GDS-15), cut-off 6] declined imagery capacity [according to the Revised Movement Imagery Questionnaire (MIQ-R) cut-off 10]
Patient description: The patient is a 55-year-old man who was recently diagnosed with Parkinson's disease. He is complaining of slowness of movement and tremors. His disease is ranked as mild, Hoehn-Yahr Stage I. His past medical history is significant for hypertension and hypercholesterolemia. He lives with his wife. They have three children. He used to be active with gardening before his diagnosis. He complains of shaking and slow movement. He had difficulty entering through a door, as he was frozen and needed guidance to step in. His handwriting is getting smaller. He is offered Levodopa and Trihexyphenidyl. He is an alert and cooperative man who does not have any signs of dementia. He does not smoke or use any illicit drugs.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Parkinson Disease Patients with Parkinson's Disease according to the of the (UK Parkinson's disease brain bank)  Insane patient arriving without a third party Patient with Parkinson's disease arising from another etiology
Patient description: The patient is a 55-year-old man who was recently diagnosed with Parkinson's disease. He is complaining of slowness of movement and tremors. His disease is ranked as mild, Hoehn-Yahr Stage I. His past medical history is significant for hypertension and hypercholesterolemia. He lives with his wife. They have three children. He used to be active with gardening before his diagnosis. He complains of shaking and slow movement. He had difficulty entering through a door, as he was frozen and needed guidance to step in. His handwriting is getting smaller. He is offered Levodopa and Trihexyphenidyl. He is an alert and cooperative man who does not have any signs of dementia. He does not smoke or use any illicit drugs.

Clinical trial eligibility criteria: eligible ages (years): 35.0-70.0,  Parkinson's Disease Idiopathic parkinson's disease (UKPDSBB criteria) Hoen and Yahr score < 4 (ON periods) Age between 35 and 70 years old Independent person at home  Dementia patient and progressive mental illness Patient with severe tremor Incapacity to walk over ten minutes Treatment influencing bone metabolism Disease influencing phosphocalcic metabolism Severe comorbidities Pregnant woman
Patient description: The patient is a 55-year-old man who was recently diagnosed with Parkinson's disease. He is complaining of slowness of movement and tremors. His disease is ranked as mild, Hoehn-Yahr Stage I. His past medical history is significant for hypertension and hypercholesterolemia. He lives with his wife. They have three children. He used to be active with gardening before his diagnosis. He complains of shaking and slow movement. He had difficulty entering through a door, as he was frozen and needed guidance to step in. His handwriting is getting smaller. He is offered Levodopa and Trihexyphenidyl. He is an alert and cooperative man who does not have any signs of dementia. He does not smoke or use any illicit drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Parkinson's Disease Age at least 18 years of age. 2. Speaks and understands English. 3. A diagnosis of idiopathic Parkinson's disease, Hoehn and Yahr Stage II or III 4. Able and willing to come to study visits (3 consecutive days, as well as 2 follow up visits, at 1 and 4 weeks) 5. Able and willing to stop therapy during the daytime for the days they come to the clinic for the study. 6. Have improvement in motor signs ON versus OFF dopaminergic medication. 7. If on medication, the patient should be on stable doses of Sinemet and/or Stalevo (Carbidopa/Levodopa Parkinson's medication) as part of their medicinal regimen (Patient does not need to be on medication to be included in the study)  Subjects, who are pregnant, are capable of becoming pregnant, or who are breast feeding. 2. Subjects with very advanced Parkinson's disease, Hoehn and Yahr stage IV on medication (non-ambulatory). 3. Have significant cognitive impairment and/or dementia, as determined by a neurologist at the Stanford Movement Disorders Clinic. 4. Have an implanted electronic device such as a cardiac pacemaker/defibrillator or medication pump. 5. Subjects who have an inability to comply with study follow-up visits. 6. Subjects who are unable to understand or sign the informed consent. 7. Have an MRI showing focal brain lesions that could indicate a non-idiopathic movement disorder. 8. Have an active infection. 9. Require diathermy, electroconvulsive therapy (ECT), or transcranial magnetic stimulation (TMS) to treat a chronic condition
Patient description: The patient is a 55-year-old man who was recently diagnosed with Parkinson's disease. He is complaining of slowness of movement and tremors. His disease is ranked as mild, Hoehn-Yahr Stage I. His past medical history is significant for hypertension and hypercholesterolemia. He lives with his wife. They have three children. He used to be active with gardening before his diagnosis. He complains of shaking and slow movement. He had difficulty entering through a door, as he was frozen and needed guidance to step in. His handwriting is getting smaller. He is offered Levodopa and Trihexyphenidyl. He is an alert and cooperative man who does not have any signs of dementia. He does not smoke or use any illicit drugs.

Clinical trial eligibility criteria: eligible ages (years): 19.0-999.0,  Hypertension Hypercholesterolemia Both man and woman who is over 19 years old Hypertension patient with hypercholesterolemia  sSBP difference is ≥20mmHg or sDBP difference is ≥10mmHg A history of cardiovascular disease rhabdomyolysis, myopathy Hypertension or hypercholesterolemia due to secondary causes Uncontrolled diabetes Evidence of hepatic or renal disease
Patient description: The patient is a 55-year-old man who was recently diagnosed with Parkinson's disease. He is complaining of slowness of movement and tremors. His disease is ranked as mild, Hoehn-Yahr Stage I. His past medical history is significant for hypertension and hypercholesterolemia. He lives with his wife. They have three children. He used to be active with gardening before his diagnosis. He complains of shaking and slow movement. He had difficulty entering through a door, as he was frozen and needed guidance to step in. His handwriting is getting smaller. He is offered Levodopa and Trihexyphenidyl. He is an alert and cooperative man who does not have any signs of dementia. He does not smoke or use any illicit drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-75.0,  Hemianopsia The subject is able to give his informed consent Stroke Hemianopsia brain damage documented by means of TAC or RMN Hemianopsia diagnosed by means automated visual field and Neurological Evaluation Time from lesion at least six months normal or corrected-to-normal visual acuity  Presence of Ophthalmologic neuropsychologic or psychiatric pathology Global cognitive deficit Presence of other neurological pathology Presence of cardiac peacemaker Presence metallic or electronic items in the head or in the body Story/familiarity of epilepsy, taking medications that can induce epileptic crisis Severe heart disease History of high alcohol consumption Pregnancy
Patient description: The patient is a 55-year-old man who was recently diagnosed with Parkinson's disease. He is complaining of slowness of movement and tremors. His disease is ranked as mild, Hoehn-Yahr Stage I. His past medical history is significant for hypertension and hypercholesterolemia. He lives with his wife. They have three children. He used to be active with gardening before his diagnosis. He complains of shaking and slow movement. He had difficulty entering through a door, as he was frozen and needed guidance to step in. His handwriting is getting smaller. He is offered Levodopa and Trihexyphenidyl. He is an alert and cooperative man who does not have any signs of dementia. He does not smoke or use any illicit drugs.

Clinical trial eligibility criteria: eligible ages (years): 7.0-10.0,  Hand Strength change Absence of skeletal muscle in the upper limbs neurological disorder Absence Informed Consent signed by the responsible with preserved cognitive consent form signed by the volunteer  Having less than 7 years old Having more than 10 years old To present some compromise skeletal muscle in the upper limbs not take part in the research
Patient description: The patient is a 55-year-old man who was recently diagnosed with Parkinson's disease. He is complaining of slowness of movement and tremors. His disease is ranked as mild, Hoehn-Yahr Stage I. His past medical history is significant for hypertension and hypercholesterolemia. He lives with his wife. They have three children. He used to be active with gardening before his diagnosis. He complains of shaking and slow movement. He had difficulty entering through a door, as he was frozen and needed guidance to step in. His handwriting is getting smaller. He is offered Levodopa and Trihexyphenidyl. He is an alert and cooperative man who does not have any signs of dementia. He does not smoke or use any illicit drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Huntington's Disease Confirmed HD diagnosis by genetic test Over 18 years of age Enrolled in the EHDN Registry/Enroll-HD study Stable medication regime 4 weeks prior to recruitment (and not anticipated to change medications during the study period)  Inability to provide consent Any known neurological condition (other than HD) Currently actively involved in any other interventional trial (i.e. have begun the intervention) or within four weeks of completing the final assessments of an interventional trial Currently regularly completing computerised brain training programme MRI contraindications (e.g. a pacemaker) as established using standard screening procedures (optional)
Patient description: The patient is a 55-year-old man who was recently diagnosed with Parkinson's disease. He is complaining of slowness of movement and tremors. His disease is ranked as mild, Hoehn-Yahr Stage I. His past medical history is significant for hypertension and hypercholesterolemia. He lives with his wife. They have three children. He used to be active with gardening before his diagnosis. He complains of shaking and slow movement. He had difficulty entering through a door, as he was frozen and needed guidance to step in. His handwriting is getting smaller. He is offered Levodopa and Trihexyphenidyl. He is an alert and cooperative man who does not have any signs of dementia. He does not smoke or use any illicit drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-90.0,  Pain, Postoperative Patients scheduled to undergo primary unilateral total hip replacement Patients diagnosed with hip osteoarthritis Patients failed to improve with conservative measures Patients willing and able to sign informed consent  Revision total hip replacement Bilateral total hip replacement Birmingham hip resurfacing Patients with hepatic/kidney disease Patients with a known allergy to bupivacaine or other local anesthetics
Patient description: The patient is a 55-year-old man who was recently diagnosed with Parkinson's disease. He is complaining of slowness of movement and tremors. His disease is ranked as mild, Hoehn-Yahr Stage I. His past medical history is significant for hypertension and hypercholesterolemia. He lives with his wife. They have three children. He used to be active with gardening before his diagnosis. He complains of shaking and slow movement. He had difficulty entering through a door, as he was frozen and needed guidance to step in. His handwriting is getting smaller. He is offered Levodopa and Trihexyphenidyl. He is an alert and cooperative man who does not have any signs of dementia. He does not smoke or use any illicit drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Parkinson Disease Parkinson's disease with motor fluctuations and dyskinesias receiving deep-brain stimulation Social insurance  No affiliation to the social insurance Patients under guardianship
Patient description: The patient is a 55-year-old man who was recently diagnosed with Parkinson's disease. He is complaining of slowness of movement and tremors. His disease is ranked as mild, Hoehn-Yahr Stage I. His past medical history is significant for hypertension and hypercholesterolemia. He lives with his wife. They have three children. He used to be active with gardening before his diagnosis. He complains of shaking and slow movement. He had difficulty entering through a door, as he was frozen and needed guidance to step in. His handwriting is getting smaller. He is offered Levodopa and Trihexyphenidyl. He is an alert and cooperative man who does not have any signs of dementia. He does not smoke or use any illicit drugs.

Clinical trial eligibility criteria: eligible ages (years): 40.0-75.0,  Parkinson Disease Parkinson disease diagnosed by United Kingdom Parkinson's disease Society Brain Bank Postural instability and gait disturbance phenotype Hoehn and Yahr stage ≤ 3 Mini-Mental status examination ≥ 24  Significant motor complication affecting daily activities Drugs related to acetylcholine metabolism
Patient description: The patient is a 55-year-old man who was recently diagnosed with Parkinson's disease. He is complaining of slowness of movement and tremors. His disease is ranked as mild, Hoehn-Yahr Stage I. His past medical history is significant for hypertension and hypercholesterolemia. He lives with his wife. They have three children. He used to be active with gardening before his diagnosis. He complains of shaking and slow movement. He had difficulty entering through a door, as he was frozen and needed guidance to step in. His handwriting is getting smaller. He is offered Levodopa and Trihexyphenidyl. He is an alert and cooperative man who does not have any signs of dementia. He does not smoke or use any illicit drugs.

Clinical trial eligibility criteria: eligible ages (years): 50.0-85.0,  PD Gait Dysfunction, Neurologic Rehabilitation Diagnosis of "probable" idiopathic Parkinson's disease according to Gelb et al (Gelb, 1999) Mild to moderate stage of disease (stage 2-3) according to Hoehn & Yahr scale Ability to walk on treadmill Visual and hearing capacity sufficient to perceive the cues No cognitive impairment (Mini-Mental State Examination score ≥ 26) Stable pharmacological treatment since 2 weeks before admission and during rehabilitation  Diagnosis of atypical or vascular Parkinsonism Occurrence of cardiovascular, orthopaedic, peripheral nerves, musculoskeletal and vestibular disorders which could affect patient's locomotion or balance Neuropsychiatric disturbances Severe dyskinesia Severe freezing of gait
Patient description: The patient is a 55-year-old man who was recently diagnosed with Parkinson's disease. He is complaining of slowness of movement and tremors. His disease is ranked as mild, Hoehn-Yahr Stage I. His past medical history is significant for hypertension and hypercholesterolemia. He lives with his wife. They have three children. He used to be active with gardening before his diagnosis. He complains of shaking and slow movement. He had difficulty entering through a door, as he was frozen and needed guidance to step in. His handwriting is getting smaller. He is offered Levodopa and Trihexyphenidyl. He is an alert and cooperative man who does not have any signs of dementia. He does not smoke or use any illicit drugs.

Clinical trial eligibility criteria: eligible ages (years): 45.0-999.0,  Parkinson Disease Presence of Parkinson's disease. PD diagnosis following the UK Parkinson's Disease Society Brain Bank Research Center (UKPDSBRC) clinical diagnostic for PD, consistent with the typical nigrostriatal denervation pattern on VMAT2 Hoehn and Yahr stages 2-4 and/or presence of PIGD features, such as history of (near) falls, slow gait, and/or freezing of gait Available space to place table in their home (approximately 6 ft x 5 ft area)  Inability to stand or walk without an assistive device History of symptoms in stance that preclude safe and comfortable participation, such as dizziness and lightheadedness, orthostasis, severe symptomatic leg or back musculoskeletal pain History of significant symptomatic cardiovascular or pulmonary disease History of active symptomatic rheumatic arthritis History of stroke or other focal brain conditions with residual sensorimotor deficits interfering with stance functions History of chronic pain syndrome requiring daily narcotic analgesics Evidence of dementia Venous stasis or severe varicosities
Patient description: The patient is a 55-year-old man who was recently diagnosed with Parkinson's disease. He is complaining of slowness of movement and tremors. His disease is ranked as mild, Hoehn-Yahr Stage I. His past medical history is significant for hypertension and hypercholesterolemia. He lives with his wife. They have three children. He used to be active with gardening before his diagnosis. He complains of shaking and slow movement. He had difficulty entering through a door, as he was frozen and needed guidance to step in. His handwriting is getting smaller. He is offered Levodopa and Trihexyphenidyl. He is an alert and cooperative man who does not have any signs of dementia. He does not smoke or use any illicit drugs.

Clinical trial eligibility criteria: eligible ages (years): 45.0-85.0,  Parkinson Disease Age 45 to 85 Diagnosis of Parkinson's Disease using the UK Brain Bank Fine motor impairments (if available, scores 2 and higher on the UPDRS motor examination part III.23 and 24) Medication stable for at least 30 days  Features suggestive of other causes of parkinsonism, including cerebrovascular disease or history of major head trauma Inability to move fingers or hands Hoehn and Yahr stage 4 and higher Ferrous metal implants which may interfere with the MEG data acquisition and/or be an MRI safety concern Dementia Participants engaged in other research studies involving music therapies Participants whose insurance does not cover Occupational Therapy costs or who have no insurance